2010
DOI: 10.1007/s00432-010-0836-5
|View full text |Cite
|
Sign up to set email alerts
|

PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of colorectal cancer cells

Abstract: Our results demonstrate that PI3K/Akt and GSK-3β prevents in a differential fashion the malignant phenotype of HCT-116 colorectal cancer cells, which could constitute a potential therapeutic target for treatment of this cancer type.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
15
0
1

Year Published

2010
2010
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(18 citation statements)
references
References 33 publications
2
15
0
1
Order By: Relevance
“…GSK-3 β , known to be a survival factor for cancer, is constitutively activated in colorectal cancer cells. Deregulation of GSK-3 β has been implicated in tumorigenesis and cancer progression including that of colorectal cancer [15]. LiCl has been shown to induce cell growth arrest, apoptosis, and terminal differentiation in various human malignant tumors by targeting GSK-3 β [16].…”
Section: Discussionmentioning
confidence: 99%
“…GSK-3 β , known to be a survival factor for cancer, is constitutively activated in colorectal cancer cells. Deregulation of GSK-3 β has been implicated in tumorigenesis and cancer progression including that of colorectal cancer [15]. LiCl has been shown to induce cell growth arrest, apoptosis, and terminal differentiation in various human malignant tumors by targeting GSK-3 β [16].…”
Section: Discussionmentioning
confidence: 99%
“…The epidermal growth factor receptor (EGFR) is dimerized and activated by its extracellular ligand, EGF, which triggers a signaling cascade that leads to the activation of cytoplasmic pathways such as MAPK and PI3K-Akt [7], [8]; these pathways are known to modulate proliferation, differentiation and resistance to cell death [9], [10]. Studies have shown that these pathways are involved in events related to the carcinogenic processes in mouse epidermal and human gastric cancer cells [11], [12], as well as in the increased migratory and invasive potential during the epithelial-mesenchymal transition in human ovarian cells [13].…”
Section: Introductionmentioning
confidence: 99%
“…Em trabalhos recentes, relatamos a participação das vias da PI3K/Akt, ERK1/2 e Rho GTPases regulando eventos da progressão deste tipo de câncer (17)(18)(19). Um resumo de nossos resultados está esquematizado na figura 2.…”
Section: Vias De Sinalização Celular Que Regulam a Progressão Dounclassified